Melanocortin & Tone

PT-141

MC4 Receptor Agonist - Bremelanotide - MC4 receptor agonist studied in melanocortin signalling.

PT-141 (Bremelanotide) is a melanocortin-receptor agonist and metabolite of Melanotan II, studied for its central role in melanocortin-receptor signalling research via the MC4 receptor.

PT-141 (Bremelanotide) is the more receptor-selective metabolite of Melanotan II, focusing on central MC4 signalling, and a bremelanotide product has reached regulatory approval for a specific indication. Research here centres on that central pathway rather than pigmentation.

PT-141 specifications

Sequence

Bremelanotide — cyclic heptapeptide

Presentation

Lyophilised powder

Documented purity

99.60% by HPLC

Available sizes

10mg ($45)

Archived COA lots

2

Intended use

Laboratory research use only. Not for human or veterinary use.

Studied pathways

• MC4 receptor - Studied for central-nervous-system arousal signalling distinct from vascular pathways.

Reported mechanisms in the literature

• Central arousal signalling - A melanocortin-receptor agonist and metabolite of Melanotan II, studied for central arousal signalling via the MC4 receptor, distinct from vascular pathways. (Molinoff et al.)

PT-141 frequently asked questions

Documented to 99.60% purity by HPLC · third-party COA every lot · from $45 · For laboratory research use only.

Related Melanocortin & Tone compounds

• Melanotan II - Melanocortin agonist studied for pigmentation research.
• Kisspeptin - Upstream regulator of the reproductive hormone axis.
• HCG - Gonadotropin studied in reproductive-endocrinology research.